✦ LIBER ✦

CP3 DISCONTINUATION RATES OF PHARMACOLOGICAL TREATMENTS FOR OVERACTIVE BLADDER: COMPARISON OF OXYBUTYNIN IMMEDIATE AND EXTENDED RELEASE IN THE UNITED KINGDOM

✍ Scribed by D Dubois; RW Simons; C Neslusan; W Feng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Canadian economic comparison of extended

✍ Denis Getsios; J.Jaime Caro; K.Jack Ishak; Wissam El-Hadi; Krista Payne 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

A comparison of extended-release oxybuty

✍ Peter K. Sand; John Miklos; Henry Ritter; Rodney Appell 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 212 KB

PUK10 Cost-Effectiveness Analysis of Sol

✍ W.M. Hart; V. Munro; P. Retsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The cost-effectiveness of solifenacin vs

✍ Linda Cardozo; Andrew Thorpe; Juliet Warner; Manpreet Sidhu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

THE COST-EFFECTIVENESS OF SOLIFENACIN VS

✍ Juliet L. Warner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB